Thrivent Financial for Lutherans’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-57,384	Closed	-$542K	–	2556
2023 Q3	$542K	Sell	57,384 -2,450	-4%	-$29.5K	﹤0.01%	2095
2023 Q2	$836K	Sell	59,834 -1,915	-3%	-$32.6K	﹤0.01%	1915
2023 Q1	$1.16M	Sell	61,749 -2,019	-3%	-$33.2K	﹤0.01%	1691
2022 Q4	$878K	Sell	63,768 -152	-0.2%	-$2.33K	﹤0.01%	1807
2022 Q3	$1.22M	Buy	63,920 +3,259	+5%	+$59.4K	﹤0.01%	1546
2022 Q2	$926K	Buy	60,661 +10,530	+21%	+$156K	﹤0.01%	1756
2022 Q1	$1.02M	Buy	50,131 +211	+0.4%	+$4.3K	﹤0.01%	1819
2021 Q4	$1.46M	Buy	+49,920	New	+$1.43M	﹤0.01%	1617

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Thrivent Financial for Lutherans's CDMO Position: Q4 2023 in Review

Thrivent Financial for Lutherans sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 57,384 shares — an estimated $542K sold.

Thrivent Financial for Lutherans first reported a position in CDMO in Q4 2021 and held it in 8 quarters. The position peaked at $1.46M in Q4 2021. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

Thrivent Financial for Lutherans reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Thrivent Financial for Lutherans sold 57,384 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $542K.
Thrivent Financial for Lutherans first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Thrivent Financial for Lutherans's Avid Bioservices, Inc. Common Stock position peaked at $1.46M in Q4 2021.
174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2023, filed 14 Feb 2024.